Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

°íÄ®½·´¢ÁõÀ» °¡Áø ¿ä¼® ȯÀÚÀÇ ÀÓ»ó Ư¡ Clinical Characteristics of Hypercalciuric Patients with Urinary Stone

´ëÇѺñ´¢±â°úÇÐȸÁö 1997³â 38±Ç 8È£ p.801 ~ 807
ÁÖ±¤·Î, ÀÌ¿ÏÇà, ±èÀ±È­, ¾ç¹®È£,
¼Ò¼Ó »ó¼¼Á¤º¸
ÁÖ±¤·Î (  ) 
°æÈñ´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç

ÀÌ¿ÏÇà (  ) 
°æÈñ´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
±èÀ±È­ (  ) 
°æÈñ´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
¾ç¹®È£ (  ) 
°æÈñ´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç

Abstract

°á·Ð
1986³â 1¿ùºÎÅÍ 1996³â 6¿ù±îÁö º»¿ø¿¡ ÀÔ¿øÇÑ 4,891¸íÀÇ ¿ä¼® ȯÀÚ Áß °íÄ®½·´¢ÁõÀ» °¡
Áø 408¸íÀÇ È¯ÀÚ¸¦ ´ë»óÀ¸·Î ¿ä¼® ȯÀÚ¿¡¼­ °íÄ®½·´¢ÁõÀÇ ÀÇÀÇ ¹× ÀÓ»óÀû Ư¡¿¡ ´ëÇÑ ÈÄÇâ
Àû Á¶»ç¸¦ ÇÏ¿© ´ÙÀ½°ú °°Àº °á°ú¸¦ ¾ò¾ú´Ù
1. ¿øÀÎÀÌ ¹àÇôÁø °íÄ®½·´¢Áõ 66·Ê Áß 36·Ê¿¡¼­´Â °íÄ®½·Ç÷ÁõÀÌ ÀÖ¾úÀ¸¸ç, ºÎ°©»ó¼± ±â´É
Ç×ÁøÁõÀ¸·Î Áø´ÜµÈ °æ¿ì°¡ 17·Ê (ÀÌ Áß 11·Ê´Â ¼ö¼ú·Î È®ÁøµÈ °æ¿ìÀÌ´Ù), Àå±â°£ ¿òÁ÷ÀÌÁö
¸øÇÑ °æ¿ì°¡ 8·Ê, °©»ó¼± ±â´É Ç×ÁøÁõÀÌ 4·Ê, Äí½Ì¾¾ ÁõÈıºÀÌ 1·Ê ¿´´Ù. ÀÌ¿Í °°ÀÌ °íÄ®½·
´¢ÁõÀº ´Ù¾çÇÑ ¿øÀÎÀ¸·Î ±¸¼ºµÈ ÁúȯÀÓÀ» È®ÀÎÇÒ ¼ö ÀÖ¾ú´Ù.
2. °í¿ä»ê¿äÁõÀº ³²ÀÚ 26.3% (61/232), ¿©ÀÚ10.8% (19/176)·Î Àüü ¿ä¼® ȯÀÚ¿¡¼­ °í¿ä»ê
´¢ÁõÀÌ ³ªÅ¸³ª´Â °Í°ú ºñ±³ÇØ À¯ÀÇÇÏ°Ô ³ô°Ô ³ªÅ¸³ª°í ÀÖ¾ú´Âµ¥ µ¿¹°¼º ´Ü¹éÁú ¼·ÃëÀÇ Áõ°¡
°¡ °í¿ä»ê ¿äÁõ¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÒ °ÍÀ¸·Î ÃßÃøµÇ¸ç, °íÄ®½·´¢Áõ°ú ¿ä¼® Çü¼º¿¡µµ ¿µÇâÀ»
¹ÌÄ£´Ù°í »ý°¢µÈ´Ù.
3. °íÄ®½·´¢Áõ ȯÀÚ¿¡¼­ Àç¹ß ¿ä¼®ÀÇ ºóµµ´Â 36.5%·Î Àüü ¿ä¼® ȯÀÚ¿¡¼­ Àç¹ß ¿ä¼®ÀÇ ºó
µµ 6.7%¿Í ºñ±³ÇØ À¯ÀÇÇÑ Â÷ÀÌ(p<0.05)¸¦ º¸¿© °íÄ®½·´¢ÁõÀÌ ¿ä¼® Çü¼º°ú Àç¹ß¿¡ Å« ¿µÇâÀ»
¹ÌÄ¡´Â °ÍÀ¸·Î »ý°¢µÈ´Ù. ÇÏÁö¸¸ °íÄ®½·´¢Áõ ȯÀÚ¿¡¼­ ¿ä¼® Àç¹ß±º°ú ºñÀç¹ß±ºÀÇ ¿äÁß Ä®½·
Æò±ÕÄ¡´Â Â÷ÀÌ°¡ ¾ø¾î ¿ä¼®ÀÇ Àç¹ß¿¡´Â °íÄ®½·´¢Áõ ÀÌ¿Ü¿¡µµ ¿©·¯ ÀÎÀÚ°¡ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸
·Î »ý°¢µÈ´Ù.
4. Ư¹ß¼º °íÄ®½·´¢Áõ ȯÀÚ Áß 41¸í¿¡¼­ °æ±¸Ä®½· ºÎÇÏ °Ë»ç¸¦ ½ÃÇàÇÑ °á°ú, Èí¼ö¼º°ú ½Å
¼º °íÄ®½·´¢ÁõÀÌ °¢°¢ 6·Ê (14.6%), ÀçÈí¼ö¼º °íÄ®½·´¢ÁõÀÌ 7·Ê (17.1%)¿´À¸¸ç 22·Ê
(53.7%)´Â ºÐ·ù°¡ µÇÁö ¾Ê¾Ò´Ù.
#ÃÊ·Ï#
Hypercalciuria is the most important risk factor in stone formation, occuring in about
50% of patients with calcium containing stone. Also, it is thought that hypercalciuria is
a heterogeneous disorder.
We studied 408 hypercalciuria patients with urinary stone for the evaluation of clinical
characteristics of hypercalciuric over eleven years from 1986 to 1996. Hyperuricosuria
was found 26.3% in male and 10.8% in female, respectively. Incidence of hyperuricosuria
in hypercalciuric patients with stone was significantly higher than that of patients with
urinary stone. The frequency of recurrent stone was 43.1% (100/232) in male, 27.8%
(49/176) in female. It was also significantly higher than that of patients with urinary
stone, but there was no difference of urinary calcium between recurrence group and
single episode group in hypercalciurics. As causes hypercalciuria, hypercalcemia was
found in 36 patients, primary hyperparathyroidism in 17, immobilization syndrome in 8,
hyperthyroidism in 4 and long term use of steroids in 1, repectively. As a result of oral
calcium loading test, absorptive and renal leak type were found 6 patients (14.6%),
respectively, resorptive type in 6 (14.6%) and 22 patients (53.7%) were not classified.
Based on our experience, we also confirmed that idiopathic hypercalciuria was the
heterogeneous sorder. High incidence of hyperuricosuria in urinary stone patients with
hypercalciuria might be related with high intake of animal protein. Hypercalciuria was
closely related with recurrence of stone but the degree of hypercalciuria was not related
with its recurrence. Classification of idiopathic hypercalciuria by oral calcium loading test
was available in half the cases.

Å°¿öµå

Hypercalciuria; Urinary stone; Hyperuriccsuria; Recurrent stone;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS